Comparison of ICS dose reduction vs. montelukast discontinuation for step-down therapy in well-controlled asthma: a pilot randomized controlled trial
Rahimi, B., Khoshnam Rad, N., Amini, S. et al. BMC Pulm Med 25, 167 (2025) https://doi.org/10.1186/s12890-025-03629-6 Abstract Background While asthma guidelines advocate for reducing inhaled corticosteroid (ICS) doses in well-controlled…